Every open market buy and sale of Tango Therapeutics, Inc. stock by its officers, directors and 10% owners over the last two years, straight from SEC Form 4 filings. Insiders are only selling over the last 12 months: $0 bought and $8.2M sold.
Buying and selling by month
open market, last 12 monthsGet an alert when TNGX insiders trade
We read every Form 4 the moment the SEC posts it and tell you when an TNGX officer, director or 10% owner buys on the open market, or sells $250K or more outside a pre-arranged plan, by email or on your phone.
Insider alerts are part of AI Pro. Start with a free account, then add AI Pro when you want the alerts.
Every TNGX insider trade
2 years · newest first| Insider | Type | Price | Held after | Filed | |||
|---|---|---|---|---|---|---|---|
| Nov 17, 2026 | John B KetchumDirector | Sale plan | 3,333 | $24.08 | $80K | 21,604 | Nov 19Form 4 |
| Nov 11, 2026 | Adam CrystalPresident, R&D | Sale plan | 5,000 | $25.00 | $125K | 115,743 | Nov 13Form 4 |
| Nov 2, 2026 | Jessica NewcombPrincipal Accounting Officer | Sale plan | 7,031 | $22.42 | $158K | 52,090 | Nov 4Form 4 |
| Nov 2, 2026 | Adam CrystalPresident, R&D | Sale plan | 5,000 | $22.42 | $112K | 115,743 | Nov 4Form 4 |
| Oct 1, 2026 | Adam CrystalPresident, R&D | Sale plan | 27,000 | $24.47 | $661K | 115,743 | Oct 5Form 4 |
| Sep 22, 2026 | Jessica NewcombPrincipal Accounting Officer | Sale plan | 8,200 | $24.22 | $199K | 59,121 | Sep 24Form 4 |
| Sep 1, 2026 | Adam CrystalPresident, R&D | Sale plan | 27,000 | $22.37 | $604K | 115,743 | Sep 3Form 4 |
| Aug 3, 2026 | Adam CrystalPresident, R&D | Sale plan | 27,000 | $27.24 | $736K | 115,743 | Aug 5Form 4 |
| Jul 1, 2026 | Adam CrystalPresident, R&D | Sale plan | 27,000 | $29.59 | $799K | 115,743 | Jul 2Form 4 |
| Jun 1, 2026 | Adam CrystalPresident, R&D | Sale plan | 27,000 | $22.87 | $618K | 115,743 | Jun 3Form 4 |
| May 1, 2026 | Adam CrystalPresident, R&D | Sale plan | 27,000 | $21.23 | $573K | 115,743 | May 5Form 4 |
| Apr 15, 2026 | Adam CrystalPresident, R&D | Sale plan | 38,460 | $25.00 | $962K | 112,622 | Apr 16Form 4 |
| Apr 1, 2026 | Adam CrystalPresident, R&D | Sale plan | 27,000 | $21.20 | $572K | 112,622 | Apr 2Form 4 |
| Mar 25, 2026 | Adam CrystalPresident, R&D | Sale plan | 12,000 | $20.11 | $241K | 112,622 | Mar 27Form 4 |
| Mar 5, 2026 | Adam CrystalPresident, R&D | Sale plan | 20,251 | $15.00 | $304K | 112,622 | Mar 9Form 4 |
TNGX insider trading FAQ
Are TNGX insiders buying or selling?
Insiders are only selling over the last 12 months. 0 insiders bought $0 of TNGX on the open market in 0 trades, and 5 sold $8.2M in 19 trades, 91% of that under pre-arranged trading plans.
When did an TNGX insider last buy shares?
Mace Rothenberg (Director) bought 20,000 shares for $74K on Nov 18, 2024, reported on Nov 18, 2024.
When did an TNGX insider last sell shares?
John B Ketchum (Director) sold 3,333 shares for $80K on Nov 17, 2026, under a pre-arranged trading plan.
What is a Form 4?
Company officers, directors and owners of more than 10% of the shares must report trades in the company's stock to the SEC on Form 4 within two business days. This page shows open market buys and sales only. Option exercises, stock awards, gifts and shares withheld for taxes are left out, since they are not decisions to buy or sell.
Why do insider sales matter less than buys?
Insiders sell for many reasons, such as taxes, diversification or a home purchase, and many sales are scheduled months ahead under a 10b5-1 trading plan. They buy on the open market mostly when they expect the shares to rise, which is why buying, and especially several insiders buying together, gets more attention.
For informational and educational purposes only. Not investment advice, and not a recommendation to buy or sell any security. Trades come from SEC Form 4 filings as reported by the insiders. Insiders have two business days to report, so a trade can be a few days old when it appears. See all insider cluster buys.
From SEC Form 4 filings · Not investment advice
